{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:50:04Z","timestamp":1787161804646,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>We discuss recent advances in evaluating and optimizing animal models of systemic sclerosis (SSc). Such models could be of value for illuminating etiopathogenesis using hypothesis-testing experimental approaches, for developing effective disease-modifying therapies, and for uncovering clinically relevant biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>We describe recent advances in previously reported and novel animal models of SSc. The limitations of each animal model and their ability to recapitulate the pathophysiology of recognized molecular subsets of SSc are discussed. We highlight attrition of dermal white adipose tissue as a consistent pathological feature of dermal fibrosis in mouse models, and its relevance to SSc-associated cutaneous fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Several animal models potentially useful for studying SSc pathogenesis have been described. Recent studies highlight particular strengths and weaknesses of selected models in recapitulating distinct features of the human disease. When used in the appropriate experimental setting, and in combination, these models singly and together provide a powerful set of in-vivo tools to define underlying mechanisms of disease and to develop and evaluate effective antifibrotic therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000331","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T12:48:46Z","timestamp":1471351726000},"page":"561-570","source":"Crossref","is-referenced-by-count":61,"title":["Animal models of scleroderma: recent progress"],"prefix":"10.1097","volume":"28","author":[{"given":"Roberta G.","family":"Marangoni","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren G.","family":"Tourtellotte","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11926-013-0382-7","article-title":"Animal models of scleroderma: current state and recent development","volume":"15","author":"Asano","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11926-015-0553-9","article-title":"Critical appraisal of the utility and limitations of animal models of scleroderma","volume":"18","author":"Tsujino","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.39658","article-title":"Identification of optimal mouse models of systemic sclerosis by interspecies comparative genomics","volume":"68","author":"Sargent","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/BOR.0b013e32834b1606","article-title":"New insights on chemically induced animal models of systemic sclerosis","volume":"23","author":"Batteux","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI119590","article-title":"Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung","volume":"100","author":"Sime","year":"1997","journal-title":"J Clin Invest"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.matbio.2014.05.002","article-title":"Tight skin 2 mice exhibit a novel time line of events leading to increased extracellular matrix deposition and dermal fibrosis","volume":"38","author":"Long","year":"2014","journal-title":"Matrix Biol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/art.38078","article-title":"Endothelial injury in a transforming growth factor beta-dependent mouse model of scleroderma induces pulmonary arterial hypertension","volume":"65","author":"Derrett-Smith","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","article-title":"Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?","volume":"73","author":"Manetti","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/annrheumdis-2015-207803","article-title":"Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice","volume":"75","author":"Manetti","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vph.2012.12.001","article-title":"The Fra-2 transgenic mouse model of systemic sclerosis","volume":"58","author":"Maurer","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2011-200940","article-title":"Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis","volume":"71","author":"Maurer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.38942","article-title":"Cardiomyopathy in murine models of systemic sclerosis","volume":"67","author":"Venalis","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/MCB.00586-15","article-title":"SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3beta","volume":"36","author":"Sundaresan","year":"2016","journal-title":"Mol Cell Biol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2014.08.011","article-title":"Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans","volume":"20","author":"Paulin","year":"2014","journal-title":"Cell Metab"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-015-0659-5","article-title":"Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis","volume":"17","author":"Ruzehaji","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/labinvest.2014.145","article-title":"A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis","volume":"95","author":"Liang","year":"2015","journal-title":"Lab Invest"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat Med"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.1780381212","article-title":"The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration","volume":"38","author":"Christner","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/jid.2014.455","article-title":"The Tsk2\/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene","volume":"135","author":"Long","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.22328","article-title":"Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma","volume":"56","author":"Sonnylal","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M300636200","article-title":"Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice","volume":"278","author":"Denton","year":"2003","journal-title":"J Biol Chem"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/rheumatology\/kes191","article-title":"Gut fibrosis with altered colonic contractility in a mouse model of scleroderma","volume":"51","author":"Thoua","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"23ra20","DOI":"10.1126\/scitranslmed.3000488","article-title":"Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome","volume":"2","author":"Loeys","year":"2010","journal-title":"Sci Transl Med"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature10145","article-title":"Lessons on the pathogenesis of aneurysm from heritable conditions","volume":"473","author":"Lindsay","year":"2011","journal-title":"Nature"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"a005017","DOI":"10.1101\/cshperspect.a005017","article-title":"Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix","volume":"3","author":"Munger","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J Dermatol Sci"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","article-title":"Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis","volume":"67","author":"Asano","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00795-015-0107-2","article-title":"Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features","volume":"48","author":"Asano","year":"2015","journal-title":"Med Mol Morphol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.25056","article-title":"The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis","volume":"62","author":"Reich","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","article-title":"Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1","volume":"105","author":"Eferl","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/BOR.0b013e32834b3309","article-title":"\u03b2-catenin signaling: a novel mediator of fibrosis and potential therapeutic target","volume":"23","author":"Lam","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","article-title":"Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis","volume":"75","author":"Zerr","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.39061","article-title":"The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling","volume":"67","author":"Wei","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2015.154","article-title":"Canonical Wnt signaling in systemic sclerosis","volume":"96","author":"Bergmann","year":"2016","journal-title":"Lab Invest"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.30312","article-title":"Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?","volume":"63","author":"Wei","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/path.4481","article-title":"Sustained beta-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes","volume":"235","author":"Hamburg-Shields","year":"2015","journal-title":"J Pathol"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jid.2016.01.036","article-title":"\u03b2-catenin stabilization in skin fibroblasts causes fibrotic lesions by preventing adipocyte differentiation of the reticular dermis","volume":"136","author":"Mastrogiannaki","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1038\/ncomms10537","article-title":"Epidermal beta-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages","volume":"7","author":"Lichtenberger","year":"2016","journal-title":"Nat Commun"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.18632\/oncotarget.796","article-title":"Endotrophin \u2013 a novel factor linking obesity with aggressive tumor growth","volume":"3","author":"Park","year":"2012","journal-title":"Oncotarget"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/ncomms4485","article-title":"Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction","volume":"5","author":"Sun","year":"2014","journal-title":"Nat Commun"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2014.22","article-title":"Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?","volume":"10","author":"Varga","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00281-015-0512-6","article-title":"Gene expression profiling offers insights into the role of innate immune signaling in SSc","volume":"37","author":"Johnson","year":"2015","journal-title":"Semin Immunopathol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201611000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T02:44:18Z","timestamp":1693277058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201611000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000331","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}